Reliance Life Sciences (RLS) is a new millennium initiative of the Reliance Group. Incorporated in the year 2001, RLS represents one of the most diverse and integrated life sciences businesses being developed anywhere in the world. RLS is driven by the vision to attain global leadership through innovative and cost-effective solutions for a better life. RLS is developing business opportunities in the domains of medical biotechnology, plant biotechnology, industrial biotechnology, clinical research services and contract manufacturing. From a domain perspective, these opportunities cover biopharmaceuticals, molecular diagnostics and genetics, cell- based therapies, plant tissue culture, plant metabolic engineering, biofuels, biopolymers, biochemicals, clinical research services and contract manufacturing. From an integration perspective, these opportunities encompass repositories, research, process development, pre-clinical studies, human clinical trials, manufacture and marketing, all of which are carried out in-house. Reliance Group is the largest private sector enterprise in India, participating in businesses in the energy and materials value chain, with group revenues of USD 24 billion. The flagship company, Reliance Industries Limited, is a Fortune Global 500 company.